150 related articles for article (PubMed ID: 10765710)
1. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
Gram LF
Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
[No Abstract] [Full Text] [Related]
2. [Neuroleptic malignant syndrome associated with olanzapine].
García López MM; Ciprés L; de Cendra E; Vilalta Franch J
Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
[No Abstract] [Full Text] [Related]
3. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic malignant syndrome and atypical antipsychotics].
Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
[No Abstract] [Full Text] [Related]
5. Atypical antipsychotics and neuroleptic malignant syndrome.
Kohen D; Bristow MF
Br J Psychiatry; 1999 Oct; 175():392-3. PubMed ID: 10789314
[No Abstract] [Full Text] [Related]
6. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
Stanfield SC; Privette T
J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine-induced neuroleptic malignant syndrome.
Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
[No Abstract] [Full Text] [Related]
8. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
Weimer E; Braus DF; Cavus I; Thome J
Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
[TBL] [Abstract][Full Text] [Related]
9. Neuropletic malignant syndrome and olanzapine.
Sierra-Biddle D; Herran A; Diez-Aja S; Gonzalez-Mata JM; Vidal E; Diez-Manrique F; Vazquez-Barquero JL
J Clin Psychopharmacol; 2000 Dec; 20(6):704-5. PubMed ID: 11106147
[No Abstract] [Full Text] [Related]
10. Neuroleptic malignant syndrome associated with olanzapine therapy.
Apple JE; Van Hauer G
Psychosomatics; 1999; 40(3):267-8. PubMed ID: 10341541
[No Abstract] [Full Text] [Related]
11. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
Mujica R; Weiden P
Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
[No Abstract] [Full Text] [Related]
12. Possible neuroleptic malignant syndrome associated with olanzapine.
Nyfort-Hansen K; Alderman CP
Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
[No Abstract] [Full Text] [Related]
13. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
Malyuk R; Gibson B; Procyshyn RM; Kang N
Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
[TBL] [Abstract][Full Text] [Related]
14. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
Melkersson K; Hulting AL
Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
[No Abstract] [Full Text] [Related]
15. Olanzapine usage associated with neuroleptic malignant syndrome.
Philibert RA; Adam LA; Frank FM; Carney-Doebbeling C
Psychosomatics; 2001; 42(6):528-9. PubMed ID: 11815691
[No Abstract] [Full Text] [Related]
16. Olanzapine-induced neuroleptic malignant syndrome with mental retardation.
Margolese HC; Chouinard G
Am J Psychiatry; 1999 Jul; 156(7):1115-6. PubMed ID: 10401467
[No Abstract] [Full Text] [Related]
17. Olanzapine and NMS.
Hickey C; Stewart C; Lippmann S
Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
[No Abstract] [Full Text] [Related]
18. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
Järventausta K; Leinonen E
Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of neuroleptic malignant syndrome with olanzapine treatment.
Gheorghiu S; Knobler HY; Drumer D
Am J Psychiatry; 1999 Nov; 156(11):1836. PubMed ID: 10553758
[No Abstract] [Full Text] [Related]
20. Atypical neuroleptic malignant syndrome?
Haggarty JM; Husni M; Peat C; Allain S
Can J Psychiatry; 1999 Sep; 44(7):711-2. PubMed ID: 10500880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
